ArticleClinicoEconomics and outcomes research : CEOR2019

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.

Jason Foo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.